Protein & Cell

Oxford University Press

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Protein & Cell is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,570 USD. Declared review time at DOAJ: 13 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
1674-800X · 1674-8018
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,570 USD
Articles in DOAJ
545
Declared review time
13 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2016-02-09
  • MEDLINE · 2010-01-01
  • PUBMED · 2013-08-27
Indexing
DOAJ · MEDLINE · PUBMED
APC
2,570 USD
Declared review time (DOAJ)
13 weeks
Actual review time (measured)
100 days received→accepted — computed from PubMed (n=73)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

545

Most recent article

5 years ago

Average review time (journal-declared via DOAJ)

13weeks

Works in OpenAlex

1774

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

131

i10-index

1108

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-03
Added to DOAJ
2016-02-09
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
84%
ORCID iDs in current deposits
82%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity4
Alternate titles
Protein and CellDanbaizhi yu xibao
Source type
journal
NLM unique ID (PubMed)
101532368
Classification4

Subjects (DOAJ)

Science: Biology (General): CytologyScience: Physiology: Animal biochemistry

LCC codes

QH573-671QP501-801

Subject areas

  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • Pluripotent Stem Cells Research
  • History of Science and Medicine
  • Enzyme Structure and Function
  • RNA modifications and cancer
Show all subjects (75)
  • RNA modifications and cancer
  • CRISPR and Genetic Engineering
  • Genomics and Chromatin Dynamics
  • Biographical and Historical Analysis
  • Protein Structure and Dynamics
  • RNA Research and Splicing
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • RNA and protein synthesis mechanisms
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Developmental Biology and Gene Regulation
  • Epigenetics and DNA Methylation
  • Autophagy in Disease and Therapy
  • Immune Response and Inflammation
  • interferon and immune responses
  • interferon and immune responses
  • RNA regulation and disease
  • RNA Research and Splicing
  • SARS-CoV-2 and COVID-19 Research
  • Mitochondrial Function and Pathology
  • Ubiquitin and proteasome pathways
  • Mitochondrial Function and Pathology
  • T-cell and B-cell Immunology
  • Ubiquitin and proteasome pathways
  • MicroRNA in disease regulation
  • interferon and immune responses
  • Ubiquitin and proteasome pathways
  • MicroRNA in disease regulation
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Animal Genetics and Reproduction
  • Protein Kinase Regulation and GTPase Signaling
  • Genetics, Aging, and Longevity in Model Organisms
  • Genetics, Aging, and Longevity in Model Organisms
  • Genetics, Aging, and Longevity in Model Organisms
  • MicroRNA in disease regulation
  • RNA regulation and disease
  • Cancer-related molecular mechanisms research
  • RNA regulation and disease
  • Immunotherapy and Immune Responses
  • Cancer-related molecular mechanisms research
  • Telomeres, Telomerase, and Senescence
  • Cellular transport and secretion
  • Gut microbiota and health
  • Immune Response and Inflammation
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • Gut microbiota and health
  • Immune Response and Inflammation
  • RNA Interference and Gene Delivery
  • Gut microbiota and health
  • RNA Interference and Gene Delivery
  • Virus-based gene therapy research
  • Virus-based gene therapy research
  • Genomics and Chromatin Dynamics
  • Genomics and Chromatin Dynamics
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Monoclonal and Polyclonal Antibodies Research
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Immune cells in cancer
  • Cancer-related Molecular Pathways

Keywords (DOAJ)

  • biochemistry
  • protein science
  • cell biology
  • stem cells
  • human genetics
  • developmental biology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: